That,in and of itself,is monumental; as Titan was moving at a seemingly snail's pace.
Without money,how do they conduct the clinical trial?
One may very well be a buyout.
Braeburn has how many Titan shares in their possession?
When they can stick to their word by keeping investors informed and can exude a semblance of togetherness at either a conference call or presentation, i'll definitely consider it.
They took the money....
How are the salaries being justified,if they've placed everything on hold until Probuphine is somewhat established?